While there is no need to change team now - Dr P does not seem to be right person to lead the company. He does too much cheerleading and used big claims.
The enrollment for adjunct trial is the biggest example - if FDA had not reduced the trial size to 30 - you can imagine the status of the company - at the current rate this trial would take 4-5 years- so the big test will come by end of Q1-2017 - whether he can meet that basic milestone. He is running small shop without much regulatory approval - so it seems he is banking on a BO and not taking the product to end.
He made big claims about mono therapy fast enrollment. We still have only one active. We beed to see when she starts activating new sites - hopefully we get some update on site this week
The product seems to be good but mgmt is not that good - but looking at possibility of a BO - we can do a 3 bagger from here so I am sticking with this stock
News 
Market Data 
Discover 
